Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dose‐dependent accumulation of glucose in the intestinal wall and lumen induced by metformin as revealed by 18F‐labelled fluorodeoxyglucose positron emission tomography‐MRI
Jun Ito, Munenobu Nogami, Yasuko Morita, et al.
Diabetes Obesity and Metabolism (2020) Vol. 23, Iss. 3, pp. 692-699
Closed Access | Times Cited: 20

Showing 20 citing articles:

Metformin: update on mechanisms of action and repurposing potential
Marc Foretz, Bruno Guigas, Benoı̂t Viollet
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 8, pp. 460-476
Open Access | Times Cited: 324
Multifaceted Mechanisms of Action of Metformin Which Have Been Unraveled One after Another in the Long History
Hideaki Kaneto, Tomohiko Kimura, Atsushi Obata, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2596-2596
Open Access | Times Cited: 57
Understanding the action mechanisms of metformin in the gastrointestinal tract
Meihui Cheng, Lili Ren, Xianxian Jia, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 14
Metformin and the Liver: Unlocking the Full Therapeutic Potential
Federica Perazza, Laura Leoni, Santo Colosimo, et al.
Metabolites (2024) Vol. 14, Iss. 4, pp. 186-186
Open Access | Times Cited: 8
Gut microbiota alterations induced by Roux-en-Y gastric bypass result in glucose-lowering by enhancing intestinal glucose excretion
Zhigang Ke, Zongshi Lu, Li Fan, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Metformin-regulated glucose flux from the circulation to the intestinal lumen
Kazuhiko SAKAGUCHI, Kenji Sugawara, Yusei Hosokawa, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access
Characteristics of tumour stroma in regional lymph node metastases in colorectal cancer patients: a theoretical framework for future diagnostic imaging with FAPI PET/CT
Meaghan Polack, Sophie C. Hagenaars, Alice M. Couwenberg, et al.
Clinical & Translational Oncology (2022) Vol. 24, Iss. 9, pp. 1776-1784
Open Access | Times Cited: 14
Oral metformin transiently lowers post-prandial glucose response by reducing the apical expression of sodium-glucose co-transporter 1 in enterocytes
Lorea Zubiaga, Olivier Briand, F. Auger, et al.
iScience (2023) Vol. 26, Iss. 4, pp. 106057-106057
Open Access | Times Cited: 8
Integrated or Independent Actions of Metformin in Target Tissues Underlying Its Current Use and New Possible Applications in the Endocrine and Metabolic Disorder Area
Giovanni Tulipano
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13068-13068
Open Access | Times Cited: 19
Metformin therapy in pediatric type 2 diabetes mellitus and its comorbidities: A review
Haifa Alfaraidi, M. Constantine Samaan
Frontiers in Endocrinology (2023) Vol. 13
Open Access | Times Cited: 7
FDG–PET findings associated with various medical procedures and treatments
Chio Okuyama, Tatsuya Higashi, Koichi Ishizu, et al.
Japanese Journal of Radiology (2022) Vol. 41, Iss. 5, pp. 459-476
Open Access | Times Cited: 11
Metformin Stimulates Intestinal Glycolysis and Lactate Release: A single‐Dose Study of Metformin in Patients With Intrahepatic Portosystemic Stent
Nikolaj Rittig, Niels Kristian Aagaard, Elias Sundelin, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 110, Iss. 5, pp. 1329-1336
Open Access | Times Cited: 13
Intestinal glucose excretion: A potential mechanism for glycemic control
Zhigang Ke, Zongshi Lu, Qing Li, et al.
Metabolism (2023) Vol. 152, pp. 155743-155743
Closed Access | Times Cited: 5
A comprehensive review on rhubarb astringent/ laxative actions and the role of aquaporins as hub genes
Ghazaleh Mosleh, Meysam Zaeri, Shiva Hemmati, et al.
Phytochemistry Reviews (2022) Vol. 22, Iss. 3, pp. 565-586
Closed Access | Times Cited: 6
Metformin action in the gut―insight provided by [18F]FDG PET imaging
Hitomi Tsuchida, Yasuko Morita, Munenobu Nogami, et al.
Diabetology International (2021) Vol. 13, Iss. 1, pp. 35-40
Open Access | Times Cited: 6
Evidence of a Gastro-Duodenal Effect on Adipose Tissue and Brain Metabolism, Potentially Mediated by Gut–Liver Inflammation: A Study with Positron Emission Tomography and Oral 18FDG in Mice
Maria Angela Guzzardi, Federica La Rosa, Daniela Campani, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2659-2659
Open Access | Times Cited: 3
High frequency of defecation under metformin use may be a potential glucose-lowering factor independent of the dose-dependent effect of metformin in patients with type 2 diabetes mellitus
Kunio Hieshima, Seigo Sugiyama, Akira Yoshida, et al.
Internal Medicine (2024)
Open Access
Is intestinal permeability increased in obesity? A review including the effects of dietary, pharmacological and surgical interventions on permeability and the microbiome
Michael Camilleri
Diabetes Obesity and Metabolism (2022) Vol. 25, Iss. 2, pp. 325-330
Open Access | Times Cited: 2
The effect of additional acarbose on metformin-associated artificially high 18F-Fluorodeoxyglucose uptake in positron emission tomography/computed tomography
Emre Urhan, Emre Temizer, Züleyha Karaca, et al.
Acta Diabetologica (2022) Vol. 59, Iss. 7, pp. 929-937
Closed Access | Times Cited: 1
[68 Ga]Ga-DOTA-FAPI-04: Focus the lesion in [18F]F-FDG hidden by metformin
Qixin Wang, Yan Zhu, Yue Chen
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 9, pp. 2914-2915
Closed Access
Page 1

Scroll to top